MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.
What was lobbied
14 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Opposed the One Big Beautiful Bill Act Joined Coalition Comments Related to H.R. 2528, the Association Health Plans Act and H.R. 2571, the Self-Insurance Protection Act Joined Coalition Comments and a Meeting Request to Discuss Pending National Coverage Analysis for Standing Systems in Power Wheelchairs Joined Coalition Comments to FDA Commissioner Makary Requesting Town Hall Meetings with Patient Advocacy Organizations Joined Coalition Comments to Congressional Leadership in Support of National Institutes of Health Joined Coalition Comments to Congressional Appropriations Leaders in Support of National Institutes of Health (6.5.2025) Wrote a Letter to Chair and Ranking Member of the House and Senate Appropriations Subcommittees on Labor, Health, Human Services and Education on FY26 Newborn Screening Program Appropriations Joined Coalition Comments to Congressional Leadership on Support for NIH and Brain Health Joined Coalition Comments to House Appropriations Leaders on Biomedical Research Joined Coalition Comments to House of Representatives Leadership on ACA Marketplace Concerns in Reconciliation Joined Coalition Comments to House and Senate Appropriations Leaders on NIAMS FY26 Appropriations Joined Coalition Comments to HHS Secretary Kennedy on Elimination of Advisory Committee on Heritable Disorders in Newborns and Children Joined Coalition Comments in Support of the HCBS Settings Rule Joined Coalition Comments in Response to the U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) for the Marketplace Integrity and Affordability Proposed Rule Submitted MDA Comments in Response to the U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) for the Marketplace Integrity and Affordability Proposed Rule Joined Coalition Comments in Support of the CONNECT for Health Act Supported the Accelerating Kids' Access to Care Act Supported a joint request for Fiscal Year 2026 Appropriations for ALS Programs Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities Expressed opposition to effort that caps indirect costs in NIH grants to 15% Supported efforts to add FSHD to the Peer Reviewed Medical Research Program Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act Continued efforts to reauthorize the ACT for ALS Supported the reintroduction of the MVP Act Supported the reintroduction of the Patient Access Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Aviation/Airlines/Airports AVI
Joined Coalition Comments to DOT re: Ensuring Lawful Regulation; Reducing Regulation and Controlling Regulatory Costs RFI
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Medicare/Medicaid MMM
Opposed the One Big Beautiful Bill Act Joined Coalition Comments and a Meeting Request to Discuss Pending National Coverage Analysis for Standing Systems in Power Wheelchairs Joined Coalition Comments in Support of the HCBS Settings Rule Joined Coalition Comments in Support of the CONNECT for Health Act Supported the Accelerating Kids' Access to Care Act Supported the reintroduction of the MVP Act Supported the reintroduction of the Patient Access Act Supported the reintroduction of the ALS Better Care Act Supported the reintroduction of the Access to Genetic Counseling Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Budget/Appropriations BUD
Joined Coalition Comments to House and Senate Appropriators to Reject Proposed Cuts to HHS (4.25.2025) Joined Coalition Comments to House and Senate Education Appropriations Leaders on Technical Assistance Centers Joined Coalition Comments to House Appropriations Leaders on Biomedical Research Joined Coalition Comments to House and Senate Appropriations Leaders on NIAMS FY26 Appropriations Joined Coalition Comments to Congressional Appropriations Leaders in Support of National Institutes of Health Wrote a Letter to Chair and Ranking Member of the House and Senate Appropriations Subcommittees on Labor, Health, Human Services and Education on FY26 Newborn Screening Program Appropriations Joined Coalition Comments to Congressional Appropriations Leaders on Administrations Draft Fiscal Year 2026 Budget for the Department of Health and Human Services Joined Coalition Comments to Congressional Appropriations Leads on FY26 Education Appropriations Supported a joint request for Fiscal Year 2026 Appropriations for ALS Programs Supported efforts to add FSHD to the Peer Reviewed Medical Research Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Medical/Disease Research/Clinical Labs MED
Joined Coalition Comments to FDA Commissioner Makary Requesting Town Hall Meetings with Patient Advocacy Organizations Joined Coalition Comments to Congressional Leadership in Support of National Institutes of Health Joined Coalition Comments to Congressional Appropriations Leaders in Support of National Institutes of Health Joined Coalition Comments to Congressional Leadership on Support for NIH and Brain Health Joined Coalition Comments to House Appropriations Leaders on Biomedical Research Joined Coalition Comments to House and Senate Appropriations Leaders on NIAMS FY26 Appropriations Expressed opposition to effort that caps indirect costs in NIH grants to 15% Supported efforts to add FSHD to the Peer Reviewed Medical Research Program Supported the reauthorization of the Rare Pediatric Disease PRV Program as part of the Gives Kids a Chance Act Continued efforts to reauthorize the ACT for ALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Pharmacy PHA
Supported Pharmacy Benefit Manager (PBM) Reform Patient Priorities
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
Agriculture AGR
Joined Coalition Comments to House Agriculture Committee on SNAP Program Cuts
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON WOOD | — |
Insurance INS
Supported the Accelerating Kids' Access to Care Act Opposed the One Big Beautiful Bill Act Joined Coalition Comments Related to H.R. 2528, the Association Health Plans Act and H.R. 2571, the Self-Insurance Protection Act Joined Coalition Comments to House of Representatives Leadership on ACA Marketplace Concerns in Reconciliation Joined Coalition Comments in Response to the U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) for the Marketplace Integrity and Affordability Proposed Rule Submitted MDA Comments in Response to the U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) for the Marketplace Integrity and Affordability Proposed Rule Supported the reintroduction of the Patient Access Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Transportation TRA
Joined Coalition Comments to DOT re: Ensuring Lawful Regulation; Reducing Regulation and Controlling Regulatory Costs RFI
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Education EDU
Joined Coalition Comments to House and Senate Education Appropriations Leaders on Technical Assistance Centers Joined Coalition Comments on Introduction of IDEA Full Funding Act Joined Coalition Comments to Congressional Appropriations Leads on FY26 Education Appropriations Submitted MDA Comments in Support of the IDEA Full Funding Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Retirement RET
Joined Coalition Comments on Confirmation of Frank Bisignano as Social Security Commissioner Joined Coalition Comments to Social Security Administration on Security Authentication PIN Emergency Request
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Taxation/Internal Revenue Code TAX
Supported the Credit for Caring Act Joined Coalition Comments in Support of Mobility Means Freedom Tax Credit Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Housing HOU
Joined Coalition Comments to Department of Housing and Urban Development on Fair Housing Revisions Interim Final Rule Joined Coalition Comments to Congressional Appropriators on FY26 Appropriations for Critical Housing Programs for Adults with Disabilities
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON WOOD | — |
Energy/Nuclear ENG
Submitted MDA Comments to U.S. Department of Energy on Section 504 Regulations Changes
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL CARTNER | — |
| PAUL MELMEYER | — |
| SHANNON WOOD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.